您当前的位置：
首页 >
文章列表页 >
Analysis of specific risks and long-term toxicities of BCR-ABL1 TKIs in pediatric patients with hematological malignancies
更新时间：2026-04-24

    • Analysis of specific risks and long-term toxicities of BCR-ABL1 TKIs in pediatric patients with hematological malignancies

    • ZHONGGUO YAOFANG   Vol. 37, Issue 8, Pages: 1050-1055(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.08.14    

      CLC： R979.1;R969.3

    • Received：23 December 2025，

      Revised：2026-03-24，

      Accepted：01 April 2026，

      Published：30 April 2026

    移动端阅览

  • WEN Luping,XIA Fan,LIAO Ziqiong,et al.Analysis of specific risks and long-term toxicities of BCR-ABL1 TKIs in pediatric patients with hematological malignancies[J].ZHONGGUO YAOFANG,2026,37(08):1050-1055. DOI： 10.6039/j.issn.1001-0408.2026.08.14.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

达沙替尼和伊马替尼的不良反应信号检测研究
国产甲磺酸伊马替尼片治疗慢性粒细胞白血病的临床观察
LC-MS/MS法测定人血浆中达沙替尼的浓度及两种片剂的生物等效性研究
贞芪扶正颗粒联合达沙替尼治疗BCR-ABL阳性白血病的临床观察
美国不良事件报告系统数据库中培美曲塞安全信号的检测

Related Author

CHEN Li
YAN Kang
WU Banghua
JIANG Juan
LI Ju
YIN Dawei
ZHU Wenjuan
TAO Chunlei

Related Institution

No data
0